(Q34452007)

2 August 2017

1 reference

title

Biological and clinical developments in melanoma vaccines (English)

1 reference

2 August 2017

Marchand M

1

1 reference

2 August 2017

Brichard V

series ordinal

2

1 reference

2 August 2017

van Baren N

series ordinal

3

1 reference

2 August 2017

Coulie PG

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

497-510

1 reference

2 August 2017

3

1 reference

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Dendritic cells as adjuvants for immune-mediated resistance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

The dual nature of specific immunological activity of tumor-derived gp96 preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.497

21 January 2018

Identifiers

DOI

10.1517/14712598.1.3.497

1 reference

2 August 2017

1 reference